LTX-315 presented at the 2012 GAP Conference in Oslo in May
Great attention to LTX-315 and positive feedback from leading cancer experts at the 2012 GAP Conference in Oslo.
The GAP Annual Conference provides a forum for faculty from MD Anderson Cancer Center and its Sister Institutions to develop collaborations and exchange research results and ideas.
Professor Gunnar Kvalheim (The Radium Hospital of Oslo University) presented LTX-315. "The presentation of the promising results we have seen with LTX-315 in our tumor stem cell model received a lot of interest, in particular from my American colleagues”, said Professor Kvalheim.
“We are very pleased that our research data received such positive feedback from leading cancer experts from MD Anderson and Sister Institutions”, said Øystein Rekdal, co-founder and Director of Oncology Research at Lytix Biopharma.